Lista de obras - Fernández M - Dominio Público Uruguay

Acute and chronic cyclooxygenase blockage in portal-hypertensive rats: influence in nitric oxide biosynthesis

artículo científico publicado en 1996

Alterations in soluble and leukocyte surface L-selectin (CD 62L) in hemodialysis patients

scientific article published on 01 November 1995

Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice.

artículo científico publicado en 2004

Antiangiogenic and antifibrogenic activity of pigment epithelium-derived factor (PEDF) in bile duct-ligated portal hypertensive rats

Disruption of negative feedback loop between vasohibin-1 and vascular endothelial growth factor decreases portal pressure, angiogenesis, and fibrosis in cirrhotic rats.

artículo científico publicado en 2014

Duration of the hemodynamic effects of N(G)-nitro-L-arginine methyl ester in vivo

scientific article published on 01 April 2000

Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in rats with long-term bile duct ligation

artículo científico publicado en 1993

Effects of the V1a vasopressin agonist F-180 on portal hypertension-related bleeding in portal hypertensive rats.

artículo científico publicado en 2003

Effects of the combined administration of propranolol plus sorafenib on portal hypertension in cirrhotic rats

artículo científico publicado en 2012

Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats.

artículo científico publicado en 1995

Gastric microcirculatory changes of portal-hypertensive rats can be attenuated by long-term estrogen-progestagen treatment

artículo científico publicado en 1994

Heme oxygenase attenuates oxidative stress and inflammation, and increases VEGF expression in portal hypertensive rats

artículo científico publicado en 2005

Hepatic endothelial dysfunction and abnormal angiogenesis: new targets in the treatment of portal hypertension.

artículo científico publicado en 2010

Hepatic, splanchnic and systemic haemodynamic abnormalities in portal hypertension

artículo científico publicado el 1 de septiembre de 1992

Impaired function of pancreatic islets from rats with portal hypertension resulting from cirrhosis and partial portal vein ligation

artículo científico publicado en 1994

Increased heme oxygenase activity in splanchnic organs from portal hypertensive rats: role in modulating mesenteric vascular reactivity.

artículo científico publicado en 2001

Increased heme oxygenase-1 gene expression in liver cells and splanchnic organs from portal hypertensive rats

artículo científico publicado en 1999

Mechanical pumping of portal blood to the liver: hemodynamic effects of a new experimental treatment for portal hypertension

artículo científico publicado en 1996

Molecular pathophysiology of portal hypertension.

artículo científico publicado en 2015

NAD(P)H oxidase modulates angiogenesis and the development of portosystemic collaterals and splanchnic hyperaemia in portal hypertensive rats.

artículo científico publicado en 2006

Neonatal capsaicin treatment does not prevent splanchnic vasodilatation in portal-hypertensive rats.

artículo científico publicado en 1994

New approaches in the pharmacologic treatment of portal hypertension.

artículo científico publicado en 1993

Noninvasive measurement of femoral blood flow and portal pressure response to propranolol in patients with cirrhosis

articulo cientifico

Pathophysiology of portal hypertension.

artículo científico publicado en 1992

Relevance of the mTOR signaling pathway in the pathophysiology of splenomegaly in rats with chronic portal hypertension.

artículo científico publicado en 2010

Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats

artículo científico publicado en 2007

Role and therapeutic potential of vascular stem/progenitor cells in pathological neovascularisation during chronic portal hypertension

artículo científico publicado en 2016

Sequential Functions of CPEB1 and CPEB4 Regulate Pathologic Expression of Vascular Endothelial Growth Factor and Angiogenesis in Chronic Liver Disease.

artículo científico publicado en 2015

Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis.

artículo científico publicado en 2004

The eNOS cofactor tetrahydrobiopterin improves endothelial dysfunction in livers of rats with CCl4 cirrhosis

artículo científico publicado en 2006

Vascular endothelial growth factor increases heme oxygenase-1 protein expression in the chick embryo chorioallantoic membrane

artículo científico publicado en 2003

Lista de obras de Fernández M

Acute and chronic cyclooxygenase blockage in portal-hypertensive rats: influence in nitric oxide biosynthesis

Alterations in soluble and leukocyte surface L-selectin (CD 62L) in hemodialysis patients

Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice.

Antiangiogenic and antifibrogenic activity of pigment epithelium-derived factor (PEDF) in bile duct-ligated portal hypertensive rats

Disruption of negative feedback loop between vasohibin-1 and vascular endothelial growth factor decreases portal pressure, angiogenesis, and fibrosis in cirrhotic rats.

Duration of the hemodynamic effects of N(G)-nitro-L-arginine methyl ester in vivo

Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in rats with long-term bile duct ligation

Effects of the V1a vasopressin agonist F-180 on portal hypertension-related bleeding in portal hypertensive rats.

Effects of the combined administration of propranolol plus sorafenib on portal hypertension in cirrhotic rats

Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats.

Gastric microcirculatory changes of portal-hypertensive rats can be attenuated by long-term estrogen-progestagen treatment

Heme oxygenase attenuates oxidative stress and inflammation, and increases VEGF expression in portal hypertensive rats

Hepatic endothelial dysfunction and abnormal angiogenesis: new targets in the treatment of portal hypertension.

Hepatic, splanchnic and systemic haemodynamic abnormalities in portal hypertension

Impaired function of pancreatic islets from rats with portal hypertension resulting from cirrhosis and partial portal vein ligation

Increased heme oxygenase activity in splanchnic organs from portal hypertensive rats: role in modulating mesenteric vascular reactivity.

Increased heme oxygenase-1 gene expression in liver cells and splanchnic organs from portal hypertensive rats

Mechanical pumping of portal blood to the liver: hemodynamic effects of a new experimental treatment for portal hypertension

Molecular pathophysiology of portal hypertension.

NAD(P)H oxidase modulates angiogenesis and the development of portosystemic collaterals and splanchnic hyperaemia in portal hypertensive rats.

Neonatal capsaicin treatment does not prevent splanchnic vasodilatation in portal-hypertensive rats.

New approaches in the pharmacologic treatment of portal hypertension.

Noninvasive measurement of femoral blood flow and portal pressure response to propranolol in patients with cirrhosis

Pathophysiology of portal hypertension.

Relevance of the mTOR signaling pathway in the pathophysiology of splenomegaly in rats with chronic portal hypertension.

Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats

Role and therapeutic potential of vascular stem/progenitor cells in pathological neovascularisation during chronic portal hypertension

Sequential Functions of CPEB1 and CPEB4 Regulate Pathologic Expression of Vascular Endothelial Growth Factor and Angiogenesis in Chronic Liver Disease.

Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis.

The eNOS cofactor tetrahydrobiopterin improves endothelial dysfunction in livers of rats with CCl4 cirrhosis

Vascular endothelial growth factor increases heme oxygenase-1 protein expression in the chick embryo chorioallantoic membrane